Survey of the incidence and aetiology of mastitis on dairy farms in England and Wales

A survey of clinical and subclinical mastitis was carried out on 97 dairy farms in England and Wales, selected at random from members of a national milk recording scheme. The farmers were asked to collect aseptic milk samples from five consecutive cases of clinical mastitis and from five quarters with high somatic cell counts using a defined protocol, and they completed a questionnaire that included information on the cows sampled, the herd and the history of mastitis in the herd. The samples were collected throughout the year. The mean incidence of clinical mastitis was 47 cases per 100 cows per year (estimated from historic farm records) and 71 cases per 100 cows per year (estimated from the samples collected). Streptococcus uberis and Escherichia coli were isolated in pure culture from 23.5 per cent and 19.8 per cent, respectively, of the clinical samples; 26.5 per cent of the clinical samples produced no growth. The most common isolates from the samples with high cell counts were coagulase-negative staphylococci (15 per cent), S uberis (14 per cent) and Corynebacterium species (10 per cent). Staphylococcus aureus and coagulase-positive staphylococci together accounted for 10 per cent of the samples with high somatic cell counts; 39 per cent produced no bacterial growth.     

Intramammary infections and risk factors for clinical mastitis in herds with low somatic cell counts in bulk milk

Ten herds with low somatic cell counts in bulk milk had an incidence of clinical mastitis of only 2.2 per 100 cows whereas 10 other herds with similarly low cell counts had an incidence of 53.6 per 100 cows. The major pathogens in the herds with a high incidence were Escherichia coli, Streptococcus uberis, Staphylococcus aureus and the coagulase-negative staphylococci. The percentage of uninfected quarters in the herds with a high incidence of clinical mastitis was 21.4 per cent compared with 12.2 per cent in the herds with a low incidence of clinical mastitis. The prevalence of coagulase-negative staphylococci, Corynebacterium bovis and Micrococcus species was higher in the herds with a low incidence of clinical mastitis. There was a significant linear relationship between the percentage of uninfected quarters and the incidence of clinical mastitis in the herds with a high incidence of clinical mastitis. In herds with a low incidence of clinical mastitis significantly less teat disinfection after milking was practised. The results suggest that infections with minor pathogens tend to protect cows against mastitis, and that teat disinfection after milking may increase the percentage of uninfected quarters and lead to an increased risk of clinical mastitis in herds with low somatic cell counts in bulk milk.     

Aetiology of clinical mastitis in six Somerset dairy herds.

Clinical mastitis was monitored in six Somerset dairy herds for one year. The herds all had three-month geometric mean bulk milk somatic cell counts of less than 250,000 cells/ml. Escherichia coli was the predominant pathogen isolated on all the farms and in all months of the year. Environmental pathogens accounted for 61.4 per cent of all cases of clinical mastitis and for 79.3 per cent of the mastitis cases in which an aetiological agent was identified. The mean annual incidence was 41.6 cases per 100 cows (range 14 to 75). Affected cows suffered a mean of 1.5 cases and 16.4 per cent of quarters suffered at least one repeat case. Mastitis due to E. coli was more severe than mastitis due to other causes and it tended to be more severe in early lactation and during the housing period. Mastitis was significantly more severe (grades 2 and 3) in the herd with the lowest bulk milk somatic cell count and in the herd which was kept indoors throughout the year than in the other four herds. Mastitis was fatal in 2.2 per cent of cases and resulted in the death of 0.6 per cent of the lactating cows.     

Progress in controlling mastitis in England and Wales

Mastitis in England and Wales has been controlled over the past 20 years while the average size of dairy herds has doubled to 65 cows. The incidence of clinical mastitis has been reduced from approximately 120 to 150 cases per 100 cows to less than 50 cases. The limited data on the prevalence of subclinical mastitis indicate that it has been reduced from over 50 per cent of cows infected to less than half this level. The application of the major mastitis control measures on the farm has doubled over the period 1973 to 1983 and had reached 66 to 90 per cent for individual measures by 1983. The national mean cell count in milk has been reduced from 573,000 to 352,000 cells/ml between 1971 and 1986, and the proportion of herds having annual mean cell counts below 300,000 cells/ml has increased from 15.7 per cent to 40.7 per cent in the last eight years.     

Costs associated with selected preventive practices and with episodes of clinical mastitis in nine herds with low somatic cell counts

Nine dairy herds (mean size, 149 cows) with bulk-tank milk somatic cell counts of less than 300,000 cells/ml and greater than 80% of cows with Dairy Herd Improvement Association linear somatic cell counts less than or equal to 4 were selected for study. Each herd was monitored for 12 consecutive months. Duplicate quarter-milk specimens were collected from each cow for bacteriologic culturing at beginning of lactation, cessation of lactation, and at the time of each clinical episode of mastitis. Streptococcus agalactiae was never isolated and Staphylococcus aureus was isolated from less than 1% of all quarters. There were 554 episodes of clinical mastitis. During the year of study, the incidence rate of clinical mastitis varied from 15.6 to 63.7% of cows among the 9 herds. Mean costs per cow per year in herd for mastitis prevention were: $10 for paper towels, $3 for nonlactating cow treatment, and $10 for teat disinfectants. Mean cost associated with clinical mastitis was $107/episode. Approximately 84% ($90) of the costs attributed to a clinical episode were associated with decreased milk production and nonsalable milk. Costs of medication and professional veterinary fees per clinical episode varied significantly among the 9 herds. Three of the herds did not have a veterinarian treat a clinical episode of mastitis during the year of study even though 2 of these herds had the first and third highest incidence rates of clinical mastitis. When calculated on a per cow in herd basis, mean costs of $40/cow/year were attributed to clinical mastitis.(ABSTRACT TRUNCATED AT 250 WORDS)     

Disposal and disease rates in British dairy herds between April 1998 and March 2002

Data derived over four years from 434 dairy herds in 1998/99 to 244 in 2001/02 revealed average disposal rates of 22.6 per cent per year, half of which were for poor fertility, mastitis and lameness. The quartile of herds with the lowest disposal rates sold an average of 11.5 per cent annually and the quartile with the highest rates sold 35.5 per cent. Average annual disease rates over the four years were as follows: for assisted calving 7.8 per cent, for digestive disease 1.2 per cent, for ketosis 0.5 per cent, for hypomagnesaemia 0.5 per cent, for hypocalcaemia 5.0 per cent and for injuries 0.8 per cent. The incidence of mastitis increased from 36.0 to 43.3 per cent of cows per year. The incidence of lameness decreased from 23.3 per cent in 1998/99 to 20.7 per cent in 2000/01 but increased to 21.9 per cent in 2001/02. Data received from the same 219 farms during the first three years showed no effective differences from the full set of data for each of the three years. The lowest annual incidences of mastitis and lameness on individual farms were below 7 per cent and 2.5 per cent, respectively. In general, housing cows in cubicles was associated with a greater risk of lameness, and housing them in straw yards with a greater risk of mastitis. However, some of the lowest rates of lameness were recorded in cubicle-housed cows and some of the lowest rates of mastitis were recorded in cows housed in yards. Larger herds were not associated, in general, with higher rates of mastitis.     

Disposal and disease rates in 340 British dairy herds

Data derived from 340 dairy herds, mainly in southern England, between April 1998 and March 1999, showed that the average total culling rate was 22.1 per cent, with 5.6 per cent for infertility, 3.6 per cent for mastitis, 1.7 per cent for lameness, 2.0 per cent for poor milk yield, 3.7 per cent for age and 5.5 per cent for miscellaneous reasons which included death. The average annual rate of assisted calvings was 8.7 per cent, of injury 0.9 per cent, digestive disease 1.3 per cent ketosis 0.4 per cent, hypomagnesaemia 0.7 per cent, hypocalcaemia 5.3 per cent, mastitis 36.6 per cent, and lameness 23.7 per cent. There was a significant association (P<0.001) between higher rates of mastitis in cows housed in straw yards as opposed to cubicles and also between higher rates of lameness in cows housed in cubicles as opposed to yards (P<0.015). However, there were farms with low rates of mastitis in cows kept in straw yards and low rates of lameness in cows kept in cubicles. Larger herds tended to have more problems with lameness and higher bulk milk somatic cell counts (BMSCC). There was a positive association between BMSCC and mastitis rate.     

Incidence of clinical mastitis on farms with low somatic cell counts in bulk milk

A total of 1140 clinical cases of mastitis, with at least one inflamed quarter, were reported on 125 farms with somatic cell counts in bulk milk less than 150,000/ml. The average annual incidence was 17.9 cases per 100 cows and ranged from none to 80 cases per 100 cows. The microorganisms most frequently isolated were Escherichia coli (16.2 per cent), coagulase negative staphylococci (13.0 per cent), Staphylococcus aureus (9.6 per cent) and Streptococcus uberis (8.0 per cent). Only two cases of Streptococcus agalactiae were found. As the incidence of clinical mastitis increased, the proportion of S aureus also increased, while the proportions of E coli, S uberis and Streptococcus dysgalactiae remained about the same. Most of the clinical cases of mastitis occurred in early lactation, in November, December and January. However, after correction for the number of calvings per month, the incidence of mastitis was highest in the early summer months.     

Investigation of risk factors for clinical mastitis in British dairy herds with bulk milk somatic cell counts less than 150,000 cells/ml

A sample of dairy farms in Great Britain with a monthly bulk milk somatic cell count of less than 150,000 cells/ml was enrolled into a 12-month prospective study. At the end of the study, a questionnaire on milking practice and other farm management practices was sent to the 482 farmers who had collected data on the occurrence of mastitis throughout the 12 months. The response rate was 93 per cent. The reported mean incidence of clinical mastitis was 36.9 cases per 100 cow-years. Factors associated with an increase in the incidence of clinical mastitis were cleaning out the straw yard less frequently than every six weeks, more than 5 per cent of cows leaking milk outside the parlour, checking the foremilk, wearing gloves during milking, an average annual milk yield of more than 7000 litres per cow, dipping or spraying teats before milking and keeping milk with a high somatic cell count out of the bulk tank. Factors associated with a decrease in the incidence of clinical mastitis were using a cloth to dry the teats after washing them as part of premilking preparation, using calving boxes for less than 40 per cent of calvings, and using both cubicles and straw yards to house dry cows, as opposed to other housing.     

Study of clinical mastitis in British dairy herds with bulk milk somatic cell counts less than 150,000 cells/ml

A 12-month prospective study of clinical mastitis was conducted in 482 British dairy herds with a bulk milk somatic cell count (BMSCC) of less than 150,000 cells/ml. The mean proportion of cows in the herd with clinical mastitis was 23.1 per cent (range 0 to 80), with a mean of 1.50 quarter cases per cow. The mean incidence rate of clinical mastitis was 36.7 quarter cases per 100 cow years (range 0 to 208.2). Twelve per cent of the quarter cases showed systemic signs, including inappetence and severe lethargy. Over 22 per cent of quarter cases occurred in the first seven days of lactation and over 50 per cent occurred in the first 90 days of lactation. Cluster analysis indicated that the main difference between herds with a low and average incidence of mastitis was the proportion of clinical cases occurring in the first seven days of lactation, 14 per cent compared with 44 per cent, respectively. The risk of severe clinical mastitis compared with mild clinical mastitis decreased significantly as the individual cow somatic cell count (SCC) in the month before clinical mastitis was diagnosed increased.     

Effects of a two-year dairy herd health management programme on udder health, use of antibiotics and longevity

Since 2003, the Research Institute of Organic Agriculture (FiBL) is realizing a herd health management programme ("pro-Q" project) focussing on udder health. The objectives of the project are: (1) to reduce antibiotic mastitis treatments, (2) to optimise udder health and (3) to improve longevity, measured as averaged number of herd lactations. The farms get expert advice in prevention and treatment on herd- and animal-level. After 2 years, treatment recordings of the 65 investigated farms showed that antibiotic mastitis therapies were reduced from 38 to 26 treatments per 100 cows and year (equals a reduction of 32%). Lactation numbers of the herds increased significantly by 0.2 lactations from 3.3 to 3.5 lactations per cow. Udder health remained constant over all farms during 2 years: theoretical bulk milk cell counts averaged constantly at around 180000 cells/ml. Improvement of udder health on farm level was significantly influenced by higher somatic cell count when the project started and enhanced by farmer's motivation and farm-veterinarians' commitment to the project.     

Environmental and managerial determinants of somatic cell counts and clinical mastitis incidence in Ohio dairy herds

A stratified-random sample of 48 Ohio dairy herds participated in a 1-year disease monitoring survey to study herd management and environmental conditions affecting udder infection and clinical mastitis incidence. The mean monthly bulk-tank somatic cell count was used as an indicator of overall udder infection. Clinical incidence was determined by monthly on-farm interviews with the dairy producers. Management and environmental conditions were assessed by direct observation as well as by personal interview of dairy managers. The final multivariable analysis-of-variance model of log bulk-tank somatic cell count had an R² value of 0.43. Lower log bulk-tank somatic cell count was found in herds with hired milkers, a clean and dry cow exercise area, clean teats following milking and fewer milking cows. The number of months spent on pasture was also significant. The final model for clinical mastitis incidence had an R² value of 0.38. Less clinical mastitis was found on farms where straw bedding was used, pre-dip was not used, where there were fewer cows, fewer person-hours per cow were spent milking cows, a greater percentage of calvings occurred in the designated calving facility, and cows spent fewer months per year on pasture. Other potentially important disease determinants could not be included in the final models because of limited sample size relative to the model degrees of freedom (six each).     

Effect of premilking teat disinfection on mastitis incidence, total bacterial count, cell count and milk yield in three dairy herds.

An iodophor teat disinfectant was applied before milking by dip or spray to 50 cows and 50 cows were left untreated in each of three commercial herds. The mean incidence of clinical mastitis was reduced by 57 per cent, the total bacterial count by 70 per cent and the count of thermoduric organisms by 32 per cent. These results were not statistically significant, except that one herd showed a significant decrease in total bacterial count. There was no effect on somatic cell count, milk production or milk iodine residues. Atmospheric iodine concentrations increased in the two herds which applied the treatment as a spray, but the levels attained were not likely to be detrimental to human health.     

Effects of a mastitis control programme on the incidence of clinical mastitis

Summary

The results of a mastitis control field experiment in Utrecht over three and a half years, including sevens herds with a total of 225 lactating cows are presented. Every case of clinical mastitis was examined bacteriologically. Quarter samples were taken routinely at an average interval of five weeks.

The incidence of clinical mastitis in each herd at the start of the experiment varied from 10 to 104 quarter cases per 100 cows per year. The majority of cases of clinical mastitis (33.1 per cent) occurred during the first month of lactation.

In 74.4 per cent of the lactations marked by clinical mastitis only a single case was observed during that lactation period. If the animals were on pasture during the first month of lactation, the incidence of clinical mastitis was significantly lower during this month, compared with the first month when they were housed. Str. dysgalactiae was the most common isolate from clinical cases (21.5 per cent). A total proportion of 40.3 per cent of the clinical cases were caused by cocci, 20.3 per cent by Gram‐negative bacteria and 16.0 per cent were bacteriologically negative. Of the clinical cases caused by streptococci and staphylococci, 33.3 per cent were preceded by subclinical infection, compared with 11.8 per cent of the clinical cases due to E. coli. The overall incidence of clinical mastitis in this experiment decreased from 47 to 31 per 100 cows per year.     

A large scale mastitis control programme in Somerset.

The results of a mastitis control programme operated in south west England for three years are given. Farmers participating in the full mastitis control group agreed to treat each cow at drying off with 500 mg benzathine cloxacillin in each quarter, to have their milking machines tested and to correct any faults, and to practise teat dipping. Data covering cell counts, milk production, milk quality and clinical mastitis, were assessed from herds taking part in the programme. Cell counts were analysed from all 507 herds taking part in the programme. Milk production records for the full mastitis control group (188 herds) over a three year period are discussed, and these results compared with milk production figures from Milk Marketing Board records from herds in the south west of England which were carrying out no specific mastitis control programme. The milk quality data compare the findings in 159 herds in the full mastitis control programme with those in 247 herds in the partial and no mastitis control groups. Cases of clinical mastitis during the three year period were recorded in 73 herds in the full mastitis control group. The problems of applying the control routines are presented with observations on clinical mastitis, bulk milk cell count, milk production and milk quality. After three years, herds in the programme had on average increased milk production by 75 gallons a cow, achieved a 14.6 per cent reduction in the incidence of clinical mastitis, and improved the milk total solids percentage by one milk quality payment class.     

A comparative field trial of cephalonium and cloxacillin for dry cow therapy for mastitis in Australian dairy cows

OBJECTIVE: To investigate and compare the therapeutic efficacy of dry cow agents containing either cephalonium or cloxacillin within Australian dairy herds. DESIGN: A treatment-control trial. METHODS: Milk from infected quarters of cows with high somatic cell counts in milk on eight Australian dairy farms was cultured to identify bacterial pathogens. Cows were randomly assigned to treatment groups and one group was treated with cephalonium at drying off and the other group was treated with cloxacillin at drying off. Milk samples from infected quarters were collected immediately after calving and were cultured for pathogens. The effect of treatment on bacteriological cure was examined and somatic cell counts from infected cows from the first two herd tests after calving were examined for a treatment effect. On four farms, milk samples were collected for culture from all cases of clinical mastitis identified within the first 7 days after calving. The effect of treatment upon incidence of clinical mastitis after calving was examined. RESULTS: There was no significant difference between treatments on quarter cure rates for new infections, for chronic infections and for infections with Staphylococcus aureus, Streptococcus agalactiae and Streptococcus uberis. Infected quarters treated with cephalonium had a significantly higher cure rate than quarters treated with cloxacillin when Corynebacterium bovis and Staphylococcus epidermids were included as pathogens combined (80.3% versus 70.7%). There was no significant difference between the treatments on somatic cell counts of infected cows at the first two herd tests after calving. There was no difference between treatments on the incidence of clinical mastitis in the first 7 days after calving.     

Herd health planning: farmers' perceptions in relation to lameness and mastitis

Between December 2002 and December 2003, the herd health planning activities on 61 dairy farms in the uk were compared with several measures of lameness and mastitis. Lameness had been reported as a problem in 53 of the herds directly by the farm and in the other eight by the nominating local veterinary practice; 54 of the farms also reported having a mastitis problem. Fifty-three (87 per cent) of the farms had some form of written herd health plan, of which 21 (40 per cent) had been in place for 12 months or less. All the farms were recording mastitis in some way, although 38 (62 per cent) of the farmers did not review these records and only four retained the results of a comprehensive record review. Farms defined as having a high incidence of mastitis were more likely to be reviewing their health records, but farms defined as having a high prevalence of lameness in a sentinel group of early lactation heifers were less likely to be reviewing their health records.     

Mastitis prevalence and the selection of dry cow therapy programmes in dairy herds

Sales of intramammary cerates to a group of 142 dairy farms over a period of two years were monitored. On the assumption that three tubes of cerate are used to treat one case of mastitis, an estimate was made of the prevalence of clinical mastitis in these herds. The prevalence in seasonal supply herds was 21 cases per 100 cows per year and the prevalence in town supply herds was 66 cases per 100 cows per year. The usage of dry cow therapy was related to changes in the prevalence of clinical mastitis in these herds. The use of whole-herd therapy reduced the prevalence of clinical mastitis in herds which had a high prevalence in the first year, but in herds with a low prevalence of clinical mastitis the prevalence increased after the use of dry cow therapy.     

Metabolic parameters and blood leukocyte profiles in cows from herds with high or low mastitis incidence

The objective of this study was to determine whether there were differences in metabolic parameters and blood leukocyte profiles between cows in herds with high or low yearly mastitis incidence. In this study, 271 cows from 20 high yielding dairy herds were examined. According to the selection criteria, all herds had low somatic cell counts. Ten of the selected herds represented low mastitis treatment incidence (LMI) and ten herds had high mastitis treatment incidence (HMI). The farms were visited once and blood samples were taken from each cow that was in the interval from three weeks before to 15 weeks after parturition. The eosinophil count was significantly lower among cows from the HMI herds in the period from four weeks to 15 weeks after parturition. The plasma concentrations of beta-hydroxybutyrate, glucose, insulin and urea did not differ between groups, but the concentration of nonesterified fatty acids was significantly higher among HMI cows during the period three weeks after parturition. The concentration of the amino acid tryptophan in plasma was significantly lower among the HMI cows prior to parturition. Glutamine was significantly lower in cows from HMI herds during the first three weeks after parturition. Arginine was consistently lower in HMI cows, although the decrease was only significant during the period from four to fifteen weeks after parturition. The results suggest that there were differences in the metabolism and immune status between herds with high or low yearly mastitis treatment incidence indicating an increased metabolic stress in HMI cows.     

Within herd comparison of teat dipping and dry cow therapy with only selective dry cow therapy in six herds

A within herd comparison of teat dipping and dry cow therapy (full treatment) with only selective dry cow therapy (partial treatment) was carried out in six commercial dairy herds for a two year period. In four herds, the incidence of clinical mastitis was 2 to 12 per cent higher in the partial treatment group. In another herd, in which the pattern of clinical mastitis isolates was unusual in that minor pathogens were isolated from 30 per cent of mastitis cases, the incidence was 43 per cent higher in the partial treatment group. In the remaining herd the incidence was 10 percent higher in the full treatment group. Streptococcus uberis mastitis was more common in the partial treatment groups of five herds; coliform mastitis was more common in the full treatment groups of two herds and similar in both groups in the other herds. High rates of coliform mastitis were associated with poor herd environmental conditions but this was not true for Strep uberis mastitis. Rates of staphylococcus aureus and Strep dysgalactiae mastitis were low in all herds. The level of major pathogen infection in cows completing the trial in all herds increased in the partial treatment group from 5 per cent of quarters at the start to 12 per cent at the finish of the trial. In the full treatment group, however, there was only a small increase in this level. In contrast, levels of Corynebacterium bovis infection increased by 17 per cent in both treatment groups. Continued use of teat dipping and dry cow therapy was associated with a higher rate of coliform mastitis in two of the three herds where there were poor standards of hygiene and husbandry.